These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22074577)

  • 1. The alteration of coagulation in patients with thyroid dysfunction.
    Akinci B; Comlekci A; Ozcan MA
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):50-7. PubMed ID: 22074577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid dysfunction and hemostasis: an issue still unresolved.
    Franchini M; Montagnana M; Manzato F; Vescovi PP
    Semin Thromb Hemost; 2009 Apr; 35(3):288-94. PubMed ID: 19452404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review.
    Squizzato A; Romualdi E; Büller HR; Gerdes VE
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2415-20. PubMed ID: 17440013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of thyroid function on the coagulation system and its clinical consequences.
    Elbers LPB; Fliers E; Cannegieter SC
    J Thromb Haemost; 2018 Apr; 16(4):634-645. PubMed ID: 29573126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and fibrinolysis in thyroid dysfunction.
    Erem C
    Endocrine; 2009 Aug; 36(1):110-8. PubMed ID: 19367377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic changes in thyroid diseases: haemostasis and thrombosis.
    Franchini M
    Hematology; 2006 Jun; 11(3):203-8. PubMed ID: 17325963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical hypothyroidism and homeostatic disturbances: case report and literature review.
    Ehsanzadeh-Cheemeh P; Thompson M; Miller M
    Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):136-8. PubMed ID: 22435391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of hemostasis in dysthyroidism].
    Klein M; Barbé F; Kaminsky P; Duc M
    Pathol Biol (Paris); 1993 Mar; 41(3):268-75. PubMed ID: 8332397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid disorders and hypercoagulability.
    Erem C
    Semin Thromb Hemost; 2011 Feb; 37(1):17-26. PubMed ID: 21249601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid and hemostasis].
    Franchini M
    Recenti Prog Med; 2006 May; 97(5):267-71. PubMed ID: 16838559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood coagulation and fibrinolytic activity in hypothyroidism.
    Erem C; Kavgaci H; Ersöz HO; Hacihasanoglu A; Ukinç K; Karti SS; Deger O; Telatari M
    Int J Clin Pract; 2003 Mar; 57(2):78-81. PubMed ID: 12661786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostasis and thyroid diseases revisited.
    Franchini M
    J Endocrinol Invest; 2004 Oct; 27(9):886-92. PubMed ID: 15648557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
    Abdulrahman RM; Delgado V; Hoftijzer HC; Ng AC; Ewe SH; Marsan NA; Holman ER; Hovens GC; Corssmit EP; Romijn JA; Bax JJ; Smit JW
    Thyroid; 2011 May; 21(5):471-6. PubMed ID: 21417919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review.
    Targher G; Pichiri I; Zoppini G; Bonora E; Chonchol M
    Semin Thromb Hemost; 2009 Oct; 35(7):605-12. PubMed ID: 20013527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of coagulation abnormalities in thyroid disorders.
    Vescovi PP; Favaloro EJ; Lippi G; Garofano M; Montagnana M; Manzato F; Franchini M
    Semin Thromb Hemost; 2011 Feb; 37(1):7-10. PubMed ID: 21249600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of pituitary and thyroid disorders on haemostasis: potential clinical implications.
    Kyriakakis N; Lynch J; Ajjan R; Murray RD
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):473-84. PubMed ID: 25753252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thyroid hormone on the cardiovascular system.
    Fazio S; Palmieri EA; Lombardi G; Biondi B
    Recent Prog Horm Res; 2004; 59():31-50. PubMed ID: 14749496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Euglobulinic fibrinolysis in hyperthyroidism and hypothyroidism].
    Girolami A; Brunetti A; Lazzarin M
    Folia Endocrinol; 1968 Jun; 21(3):373-84. PubMed ID: 5756116
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperthyroidism and venous thrombosis: a casual or causal association? A systematic literature review.
    Franchini M; Lippi G; Targher G
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):387-92. PubMed ID: 20308227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.